Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals-Reference-Cited by-同舟云学术

Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals

Published:2016-06-01 Issue:5 Volume:64 Page:1442-1450
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Chhatwal Jagpreet¹²³,Wang Xiaojie⁴⁵,Ayer Turgay⁴,Kabiri Mina⁶,Chung Raymond T.²³,Hur Chin¹²³,Donohue Julie M.⁶,Roberts Mark S.⁶,Kanwal Fasiha⁷⁸

Affiliation:

1. Massachusetts General Hospital Institute for Technology Assessment; Boston MA

2. Harvard Medical School; Boston MA

3. Liver Center and Gastrointestinal Division; Massachusetts General Hospital; Boston MA

4. H. Milton Stewart School of Industrial and Systems Engineering; Georgia Institute of Technology; Atlanta GA

5. Department of Industrial and Systems Engineering; University of Florida; Gainesville FL

6. Department of Health Policy and Management; University of Pittsburgh; Pittsburgh PA

7. Houston Veterans Affairs Health Services Research and Development Center of Excellence; Michael E. DeBakey Veterans Affairs Medical Center; Houston TX

8. Department of Medicine, Gastroenterology and Hepatology; Baylor College of Medicine; Houston TX

Funder

National Institutes of Health

Gilead Sciences, Inc.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28571/fullpdf

Reference37 articles.

1. Chronic hepatitis C infection;Rosen;N Engl J Med,2011

2. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010;Denniston;Ann Intern Med,2014

3. Toward a more accurate estimate of the prevalence of hepatitis C in the United States;Edlin;Hepatology,2015

4. Screening for hepatitis C virus Infection in adults: U.S. Preventive Services Task Force Recommendation Statement;Moyer;Ann Intern Med,2013

5. The changing burden of hepatitis C in the United States: model-based predictions;Kabiri;Ann Intern Med,2014

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals;Clinical Gastroenterology and Hepatology;2024-01

2. Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication;Alimentary Pharmacology & Therapeutics;2023-11-13

3. Hepatitis C Elimination in Moldova Is Feasible and Cost-Saving: A Modeling Study;The Journal of Infectious Diseases;2023-09-13

4. Unmet Needs in the Post–Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication;The Journal of Infectious Diseases;2023-09-13

5. Localized delivery of nanomedicine and antibodies for combating COVID-19;Acta Pharmaceutica Sinica B;2022-09